19Dec 2023
MASLD, Hepatic Steatosis, and Fibrosis in the Complex Landscape of Type 1 Diabetes Complications

MASLD, Hepatic Steatosis, and Fibrosis in the Complex Landscape of Type 1 Diabetes Complications

A comprehensive study on type 1 diabetes mellitus (T1DM) reveals that metabolic dysfunction-associated steatotic liver disease (MASLD), with or without fibrosis, is linked to a higher prevalence of chronic kidney disease (CKD) and diabetic retinopathy. Patients with MASLD and significant fibrosis exhibited a notably elevated risk (1.76 times) of CKD, while those with MASLD without fibrosis had a higher risk of retinopathy. This groundbreaking cross-sectional research, encompassing a large cohort, underscores the independent association between MASLD and these complications in adults with T1DM, emphasizing the need for targeted interventions.

  • #endo-diabetology

Like

Save

Share